CU6 Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$53,400.00
Insider Selling (Last 12 Months): A$0.00

Clarity Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Clarity Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Clarity Pharmaceuticals Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 06/27/2022 12:08 PM ET

This chart shows the closing price history over time for CU6 up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Clarity Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/22/2022Charles O'Bryan-TearInsiderBuy120,000A$0.45A$53,400.00
See Full Table

SEC Filings (Institutional Ownership Changes) for Clarity Pharmaceuticals (ASX:CU6)

Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, develops theranostic therapy and imaging products for the treatment of cancer in children and adults. Its lead product includes SARTATE, a targeted theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express somatostatin receptor 2. The company is also developing SAR-Bombesin, a pan cancer theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express gastrin releasing peptide receptor; and SAR-bisPSMA, a theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express prostate specific membrane antigen. The company has collaboration with GU Research Network for an investigator initiated Trial X-Calibur, using 64Cu-SAR-bisPSMA in known or suspected prostate cancer. Clarity Pharmaceuticals Ltd was incorporated in 2010 and is based in Sydney, Australia.
Read More on Clarity Pharmaceuticals

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Clarity Pharmaceuticals?

Clarity Pharmaceuticals' top insider shareholders include:
  1. Charles O'Bryan-Tear (Insider)
Learn More about top insider investors at Clarity Pharmaceuticals.